JP2008541759A5 - - Google Patents

Info

Publication number

JP2008541759A5

JP2008541759A5 JP2008514767A JP2008514767A JP2008541759A5 JP 2008541759 A5 JP2008541759 A5 JP 2008541759A5 JP 2008514767 A JP2008514767 A JP 2008514767A JP 2008514767 A JP2008514767 A JP 2008514767A JP 2008541759 A5 JP2008541759 A5 JP 2008541759A5

Authority

JP

Japan

Prior art keywords

polypeptide

composition

subject

treating

seq

Prior art date

2006-05-26

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000013598 vector Substances 0.000 claims 7
• 239000003814 drug Substances 0.000 claims 5
• 208000027866 inflammatory disease Diseases 0.000 claims 5
• 238000004519 manufacturing process Methods 0.000 claims 5
• 229920001184 polypeptide Polymers 0.000 claims 5
• 102000004196 processed proteins & peptides Human genes 0.000 claims 5
• 108090000765 processed proteins & peptides Proteins 0.000 claims 5
• 102000004127 Cytokines Human genes 0.000 claims 4
• 108090000695 Cytokines Proteins 0.000 claims 4
• 238000011319 anticancer therapy Methods 0.000 claims 4
• 230000003308 immunostimulating effect Effects 0.000 claims 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
• 230000004770 neurodegeneration Effects 0.000 claims 3
• 208000015122 neurodegenerative disease Diseases 0.000 claims 3
• 238000006467 substitution reaction Methods 0.000 claims 3
• 230000001225 therapeutic effect Effects 0.000 claims 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 2
• 125000003275 alpha amino acid group Chemical group 0.000 claims 2
• 150000001413 amino acids Chemical class 0.000 claims 2
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 2
• 208000004296 neuralgia Diseases 0.000 claims 2
• 208000021722 neuropathic pain Diseases 0.000 claims 2
• 108020004707 nucleic acids Proteins 0.000 claims 2
• 102000039446 nucleic acids Human genes 0.000 claims 2
• 150000007523 nucleic acids Chemical class 0.000 claims 2
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 2
• 239000013607 AAV vector Substances 0.000 claims 1
• 208000024827 Alzheimer disease Diseases 0.000 claims 1
• 108091026890 Coding region Proteins 0.000 claims 1
• 241000702421 Dependoparvovirus Species 0.000 claims 1
• 208000023105 Huntington disease Diseases 0.000 claims 1
• 208000018737 Parkinson disease Diseases 0.000 claims 1
• 201000006417 multiple sclerosis Diseases 0.000 claims 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
• 239000013612 plasmid Substances 0.000 claims 1
• 230000001105 regulatory effect Effects 0.000 claims 1
• 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
• 210000002845 virion Anatomy 0.000 claims 1